This study provides a preliminary investigation of the mechanisms that generate CD8+ T‐cell exhaustion in CRC tumour tissue and stratifies patient prognosis and immunotherapy responsiveness based on phenotypic markers of exhaustion. This evidence concerns the gene CD8A and neoplasm.